{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T16:22:44Z","timestamp":1774023764524,"version":"3.50.1"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The definition of Takayasu arteritis (TAK) remission and disease activity is still unclear. Vascular imaging is an essential tool for following-up patients. Herein, we aimed to compare the evolution of vascular lesions (i.e. vessel wall thickening and stenosis) under conventional cDMARDs relatively to biological DMARDs (bDMARDs) in TAK patients followed with the same CT angiography modalities.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Method<\/jats:title>\n                  <jats:p>We compared 75 lines of therapy in TAK patients who received cDMARDs (n\u2009=\u200940 lines) and bDMARDs (n\u2009=\u200935 lines) using CT angiography. We established 1\u20133 main target vessels with vessel wall thickening and\/or stenosis. Every targeted vessel had its thickness and its lumen diameter measured at the initiation of immunosuppressive treatment and at 12\u2009months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We observed an overall reduction in arterial wall thickness in 73% of cases and 31% had &amp;gt;25% relative decrease in the wall thickness. Using a linear mixed effects model, first-line immunosuppressive therapy (P = 0.012) and bDMARDs relatively to cDMARDs (P = 0.026) were independently associated with vessel wall thickness reduction in TAK. Thirty-eight percent of the stenotic vessels had a\u2009&amp;gt;\u200925% relative increase in lumen diameter under immunosuppressive therapy. The relative increase &amp;gt;25% in lumen diameter was noted in 56% vs 17% with bDMARDs compared with cDMARDs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Immunosuppressive treatments can reduce arterial wall thickness and widen lumen diameter in TAK. bDMARDs seem to be more effective than cDMARDs to improve arterial lesions in TAK.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae331","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T08:04:16Z","timestamp":1720253056000},"page":"675-681","source":"Crossref","is-referenced-by-count":3,"title":["Impact of conventional and biological disease-modifying anti-rheumatic drugs on arterial lesions in Takayasu arteritis"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2496-6989","authenticated-orcid":false,"given":"Diego","family":"Bletry","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Centre de R\u00e9f\u00e9rence des Maladies Auto-Immunes Syst\u00e9miques Rares, Centre de R\u00e9f\u00e9rence des Maladies Auto-Inflammatoires et de l\u2019Amylose inflammatoire (CEREMAIA), Sorbonne Universit\u00e9s, Paris, France; INSERM, UMR_S 959, AP-HP, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re , Paris,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Meyblum","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Sorbonne Universit\u00e9s, Piti\u00e9-Salp\u00eatri\u00e8re University Hospital , Paris,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristell","family":"Desseaux","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Medical Information, AP-HP Saint-Louis University Hospital, ECSTRRA Team, CRESS UMR 1153, INSERM, University of Paris , Paris,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Vautier","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Centre de R\u00e9f\u00e9rence des Maladies Auto-Immunes Syst\u00e9miques Rares, Centre de R\u00e9f\u00e9rence des Maladies Auto-Inflammatoires et de l\u2019Amylose inflammatoire (CEREMAIA), Sorbonne Universit\u00e9s, Paris, France; INSERM, UMR_S 959, AP-HP, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re , Paris,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Chiche","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, AP-HP, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re , Paris,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Le Joncour","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Centre de R\u00e9f\u00e9rence des Maladies Auto-Immunes Syst\u00e9miques Rares, Centre de R\u00e9f\u00e9rence des Maladies Auto-Inflammatoires et de l\u2019Amylose inflammatoire (CEREMAIA), Sorbonne Universit\u00e9s, Paris, France; INSERM, UMR_S 959, AP-HP, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re , Paris,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alban","family":"Redheuil","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Imaging, Sorbonne Universit\u00e9s, Piti\u00e9-Salp\u00eatri\u00e8re University Hospital , Paris,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Roux","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Sorbonne Universit\u00e9s, Piti\u00e9-Salp\u00eatri\u00e8re University Hospital , Paris,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Cacoub","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Centre de R\u00e9f\u00e9rence des Maladies Auto-Immunes Syst\u00e9miques Rares, Centre de R\u00e9f\u00e9rence des Maladies Auto-Inflammatoires et de l\u2019Amylose inflammatoire (CEREMAIA), Sorbonne Universit\u00e9s, Paris, France; INSERM, UMR_S 959, AP-HP, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re , Paris,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Gaudric","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, AP-HP, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re , Paris,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucie","family":"Biard","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Medical Information, AP-HP Saint-Louis University Hospital, ECSTRRA Team, CRESS UMR 1153, INSERM, University of Paris , Paris,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Saadoun","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Centre de R\u00e9f\u00e9rence des Maladies Auto-Immunes Syst\u00e9miques Rares, Centre de R\u00e9f\u00e9rence des Maladies Auto-Inflammatoires et de l\u2019Amylose inflammatoire (CEREMAIA), Sorbonne Universit\u00e9s, Paris, France; INSERM, UMR_S 959, AP-HP, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re , Paris,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,7,5]]},"reference":[{"key":"2025032905205653300_keae331-B1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/rheumatology\/key040","article-title":"Takayasu arteritis: advanced understanding is leading to new horizons","volume":"58","author":"Tombetti","year":"2019","journal-title":"Rheumatology"},{"key":"2025032905205653300_keae331-B2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s13023-021-01922-1","article-title":"French recommendations for the management of Takayasu\u2019s arteritis","volume":"16","author":"Saadoun","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"2025032905205653300_keae331-B3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.revmed.2015.10.353","article-title":"Usefulness of imaging in large vessel vasculitis","volume":"37","author":"Mekinian","year":"2016","journal-title":"La Rev M\u00e9d Interne"},{"key":"2025032905205653300_keae331-B4","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jvs.2007.01.016","article-title":"Patterns of aortic involvement in Takayasu arteritis and its clinical implications: evaluation with spiral computed tomography angiography","volume":"45","author":"Chung","year":"2007","journal-title":"J Vasc Surg"},{"key":"2025032905205653300_keae331-B5","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/annrheumdis-2017-212649","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice","volume":"77","author":"Dejaco","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2025032905205653300_keae331-B6","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1093\/rheumatology\/keq171","article-title":"Assessment of disease activity and progression in Takayasu\u2019s arteritis with Disease Extent Index-Takayasu","volume":"49","author":"Aydin","year":"2010","journal-title":"Rheumatology"},{"key":"2025032905205653300_keae331-B7","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/rheumatology\/ket128","article-title":"Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010)","volume":"52","author":"Misra","year":"2013","journal-title":"Rheumatology"},{"key":"2025032905205653300_keae331-B8","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/art.22404","article-title":"Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients","volume":"56","author":"Maksimowicz-McKinnon","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2025032905205653300_keae331-B9","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s00330-002-1518-8","article-title":"Value of F-18 FDG hybrid camera PET and MRI in early Takayasu aortitis","volume":"13","author":"Meller","year":"2003","journal-title":"Eur Radiol"},{"key":"2025032905205653300_keae331-B10","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1136\/ard-2022-223482","article-title":"2022 American College of Rheumatology\/EULAR classification criteria for Takayasu arteritis","volume":"81","author":"Grayson","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2025032905205653300_keae331-B11","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/S0167-5273(96)88783-3","article-title":"Diagnostic criteria for Takayasu arteritis","volume":"54","author":"Sharma","year":"1996","journal-title":"Int J Cardiol"},{"key":"2025032905205653300_keae331-B12","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1253\/circj.CJ-11-1108","article-title":"Improved prognosis of Takayasu arteritis over the past decade: comprehensive analysis of 106 patients","volume":"76","author":"Ohigashi","year":"2012","journal-title":"Circ J"},{"key":"2025032905205653300_keae331-B13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13075-017-1316-y","article-title":"TNF inhibitors appear to inhibit disease progression and improve outcome in Takayasu arteritis; an observational, population-based time trend study","volume":"19","author":"Gudbrandsson","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2025032905205653300_keae331-B14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2018.04.002","article-title":"Efficacy of tocilizumab in Takayasu arteritis: multicenter retrospective study of 46 patients","volume":"91","author":"Mekinian","year":"2018","journal-title":"J Autoimmun"},{"key":"2025032905205653300_keae331-B15","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1097\/MD.0000000000000486","article-title":"Effect of glucocorticoid treatment on computed tomography angiography detected large-vessel inflammation in giant-cell arteritis. A prospective, longitudinal study","volume":"94","author":"Prieto-Gonz\u00e1lez","year":"2015","journal-title":". Medicine"},{"key":"2025032905205653300_keae331-B16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1259\/0007-1285-59-699-281","article-title":"Takayasu\u2019s arteritis: decrease in aortic wall thickening following steroid therapy, documented by CT","volume":"59","author":"Hayashi","year":"1986","journal-title":"BJR"},{"key":"2025032905205653300_keae331-B17","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/00004728-200111000-00015","article-title":"Follow-up electron beam CT for the management of early phase Takayasu arteritis","volume":"25","author":"Paul","year":"2001","journal-title":"J Comput Assist Tomogr"},{"key":"2025032905205653300_keae331-B18","first-page":"1793","article-title":"Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu\u2019s arteritis","volume":"30","author":"Valsakumar","year":"2003","journal-title":"J Rheumatol"},{"key":"2025032905205653300_keae331-B19","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3348\/kjr.2007.8.4.286","article-title":"Follow-up CT evaluation of the mural changes in active Takayasu arteritis","volume":"8","author":"Kim","year":"2007","journal-title":"Korean J Radiol"},{"key":"2025032905205653300_keae331-B20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.55563\/clinexprheumatol\/z6drbj","article-title":"The effects of biological agents on vascular structural lesions in Takayasu\u2019s arteritis","volume":"39(Suppl 129)","author":"Erbasan","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"2025032905205653300_keae331-B21","doi-asserted-by":"crossref","first-page":"15979","DOI":"10.1038\/s41598-018-34395-7","article-title":"Novel angiographic scores for evaluation of large vessel vasculitis","volume":"8","author":"Tombetti","year":"2018","journal-title":"Sci Rep"},{"key":"2025032905205653300_keae331-B22","doi-asserted-by":"crossref","first-page":"e001977","DOI":"10.1136\/rmdopen-2021-001977","article-title":"Vessel inflammation and morphological changes in patients with large vessel vasculitis: a retrospective study","volume":"8","author":"Besutti","year":"2022","journal-title":"RMD Open"},{"key":"2025032905205653300_keae331-B23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/art.42290","article-title":"Association of 18F-Fluorodeoxyglucose \u2013positron emission tomography activity with angiographic progression of disease in large vessel vasculitis","volume":"75","author":"Quinn","year":"2023","journal-title":"Arthritis Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae331\/58474020\/keae331.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/2\/675\/58474020\/keae331.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/2\/675\/58474020\/keae331.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T03:24:54Z","timestamp":1743391494000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/2\/675\/7708402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,5]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,7,5]]},"published-print":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae331","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,7,5]]}}}